EDGAR·FLOW

Foghorn Therapeutics Inc. — Form 8-K

Filed October 1, 2026 · analyzed by the 8-K Agent
8-K ▼ Likely negative significance 72/100
What the filing says
Foghorn and Eli Lilly terminated the FHD-909 (SMARCA2 degrader) program on October 1, 2026, following Phase 1 data showing inadequate efficacy despite favorable safety. The Selective SMARCA2 degrader program is also discontinued. Foghorn will implement a 40% workforce reduction and reprioritize resources toward wholly owned programs (EP300 degrader, oral immunology/inflammation program, CBP degrader, induced proximity platform) to extend cash runway into H2 2029.
Why this rating

Loss of major partnership and lead program; 40% headcount cut; extends only to H2 2029. Meaningful relative to $172M market cap but company retains proprietary pipeline and near-term runway.

Tradability signal
SHORT conviction 38/100 · expected -0.67% over 4 hrs

SHORT (drift): bad news keeps sliding after dissemination — our one persistent measured edge. Similar past filings (112 in this cell) moved +0.82% in the called direction over 4 hrs; shrunk for sample size that's a +0.67% edge. Price is down 45.4% since the filing hit EDGAR — the slide has begun. Caution: sub-$5 shorts can be hard to borrow — treat as avoid-longs if no locate. Exit plan: HARD stop 8% against entry — 1.4× this stock's measured hourly volatility, fixed, not trailing (trails test terribly on these names) — time exit 4 hrs. (Filing arrived outside market hours — evaluated at the next open with a live quote.)

Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.

Price action (we called it negative)
at our read · unknown
$1.96
+10 min · unknown
$1.85 ▼ 5.61%
+30 min · unknown
$1.96 ▲ 0.00%
+1 hr · unknown
$2.19 ▲ 11.99%
+4 hrs · unknown
$2.67 ▲ 36.22%

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ FHTX · stock on Yahoo Finance ↗

See more from October 1, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.